CanScan
Blood-based multi-cancer early detection test using low-depth WGS and AI integration of fragmentomic, genomic and inferred epigenomic cfDNA features.
- Developer
- Geneseeq
- Intended use
- Multi Cancer Screening
- Cancer scope
- Not reported
- Specimen
- Peripheral whole blood
- Molecular modality
- Fragmentomics, Multi-omics
- Current version
- CanScan current MCED configuration
- Evidence context
- 0 structured studies · 0 indexed performance results · 2 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.